Cargando…

Fisetin ameliorates atherosclerosis by regulating PCSK9 and LOX-1 in apoE(-/-) mice

The purpose of the current study was to investigate the mechanism by which fisetin improves atherosclerosis (AS) by regulating lipid metabolism and senescence in apolipoprotein E-deficient (apoE(-/-)) mice. An AS model was established by feeding apoE(-/-) mice a high-fat diet. Mice were randomly div...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Li, Jia, Qingling, Cao, Hui, Chen, Chuan, Xing, Sanli, Huang, Yan, Shen, Dingzhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690243/ https://www.ncbi.nlm.nih.gov/pubmed/33262811 http://dx.doi.org/10.3892/etm.2020.9457

Ejemplares similares

Quercetin has a protective effect on atherosclerosis via enhancement of autophagy in ApoE(−/−) mice
por: Cao, Hui, et al.
Publicado: (2019)

Quercetin protects against atherosclerosis by regulating the expression of PCSK9, CD36, PPARγ, LXRα and ABCA1
por: Jia, Qingling, et al.
Publicado: (2019)

Effect of BuShen JiangZhi Recipe on Atherosclerosis in ApoE(−/-) Mice by Regulating the Expression of Anpep via mmu_circRNA_22187
por: Yan, Li, et al.
Publicado: (2021)

Quercetin Suppresses the Progression of Atherosclerosis by Regulating MST1-Mediated Autophagy in ox-LDL-Induced RAW264.7 Macrophage Foam Cells
por: Cao, Hui, et al.
Publicado: (2019)

Role of PCSK9 in Homocysteine-Accelerated Lipid Accumulation in Macrophages and Atherosclerosis in ApoE(−/−) Mice
por: Jin, Ping, et al.
Publicado: (2021)

Quercetin protects against ox-LDL-induced injury via regulation of ABCAl, LXR-α and PCSK9 in RAW264.7 macrophages
por: Li, Shanshan, et al.
Publicado: (2018)

Aerobic Exercise Training Inhibits Neointimal Formation via Reduction of PCSK9 and LOX-1 in Atherosclerosis
por: Li, Wei, et al.
Publicado: (2020)

PCSK9 and Atherosclerosis - Lipids and Beyond
por: Shapiro, Michael D., et al.
Publicado: (2017)

An Update on the Role of PCSK9 in Atherosclerosis
por: Yurtseven, Ece, et al.
Publicado: (2020)

Ursolic Acid Attenuates Atherosclerosis in ApoE(−/−) Mice: Role of LOX-1 Mediated by ROS/NF-κB Pathway
por: Li, Qiu, et al.
Publicado: (2018)

Ticagrelor suppresses oxidized low-density lipoprotein-induced endothelial cell apoptosis and alleviates atherosclerosis in ApoE(−/−) mice via downregulation of PCSK9
por: Xia, Xiaodong, et al.
Publicado: (2019)

Fibroblast growth factor 21 inhibits atherosclerosis in apoE−/− mice by ameliorating Fas-mediated apoptosis
por: Yan, Xinxin, et al.
Publicado: (2018)

Hyperlipidemia-induced apoptosis of hippocampal neurons in apoE(−/−) mice may be associated with increased PCSK9 expression
por: Zhao, Xue-Shan, et al.
Publicado: (2017)

Aβ promotes CD38 expression in senescent microglia in Alzheimer’s disease
por: Hu, Yiran, et al.
Publicado: (2022)

Expanding Biology of PCSK9: Roles in Atherosclerosis and Beyond
por: Seidah, Nabil G., et al.
Publicado: (2022)

Interleukin-27 Ameliorates Atherosclerosis in ApoE(−/−) Mice through Regulatory T Cell Augmentation and Dendritic Cell Tolerance
por: Xu, Wenbin, et al.
Publicado: (2022)

Early induction of oxidative stress in a mouse model of Alzheimer’s disease with heme oxygenase activity
por: XING, SANLI, et al.
Publicado: (2014)

Effect of the herbal formulation Shen-Zhi-Ling on an APP/PS1 mouse model of Alzheimer's disease by modulating the biliverdin reductase/heme oxygenase 1 system
por: Xing, Sanli, et al.
Publicado: (2017)

Nicotinamide phosphoribosyltransferase-related signaling pathway in early Alzheimer's disease mouse models
por: Xing, Sanli, et al.
Publicado: (2019)

Capsaicin Ameliorates High-Fat Diet-Induced Atherosclerosis in ApoE(−/−) Mice via Remodeling Gut Microbiota
por: Dai, Zijian, et al.
Publicado: (2022)

Ginger essential oil and citral ameliorates atherosclerosis in ApoE(−/−) mice by modulating trimethylamine-N-oxide and gut microbiota
por: Panyod, Suraphan, et al.
Publicado: (2023)

Berberine attenuates atherosclerotic lesions and hepatic steatosis in ApoE(-/-) mice by down-regulating PCSK9 via ERK1/2 pathway
por: Ma, Chun-Yan, et al.
Publicado: (2021)

Adipokine Chemerin Stimulates Progression of Atherosclerosis in ApoE(−/−) Mice
por: Liu, Huadong, et al.
Publicado: (2019)

New developments in atherosclerosis: clinical potential of PCSK9 inhibition
por: Giunzioni, Ilaria, et al.
Publicado: (2015)

PCSK9/LDLR System and Rheumatoid Arthritis-Related Atherosclerosis
por: Arida, Aikaterini, et al.
Publicado: (2021)

Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis
por: Punch, Emily, et al.
Publicado: (2022)

The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction
por: Keeter, William Coles, et al.
Publicado: (2022)

Lunasin Improves the LDL-C Lowering Efficacy of Simvastatin via Inhibiting PCSK9 Expression in Hepatocytes and ApoE(−/−) Mice
por: Gu, Lili, et al.
Publicado: (2019)

LOX-1, OxLDL, and Atherosclerosis
por: Pirillo, Angela, et al.
Publicado: (2013)

BAFF Receptor mAb Treatment Ameliorates Development and Progression of Atherosclerosis in Hyperlipidemic ApoE(−/−) Mice
por: Kyaw, Tin, et al.
Publicado: (2013)

Exogenous interleukin 37 ameliorates atherosclerosis via inducing the Treg response in ApoE-deficient mice
por: Ji, Qingwei, et al.
Publicado: (2017)

SUN-580 PCSK9 and Lp(a): Association Between PCSK9 Level and Larger Apo(a) Isoform Size in African-Americans and Caucasians
por: Byambaa, Enkhmaa, et al.
Publicado: (2020)

Decreased APOE-containing HDL subfractions and cholesterol efflux capacity of serum in mice lacking Pcsk9
por: Choi, Seungbum, et al.
Publicado: (2013)

Anti-PCSK9 antibodies inhibit pro-atherogenic mechanisms in APOE*3Leiden.CETP mice
por: Schuster, Susanne, et al.
Publicado: (2019)

PCSK9 Functions in Atherosclerosis Are Not Limited to Plasmatic LDL-Cholesterol Regulation
por: Luquero, Aureli, et al.
Publicado: (2021)

Interactions between PCSK9 and NLRP3 inflammasome signaling in atherosclerosis
por: Wang, Yanan, et al.
Publicado: (2023)

LOX-1 Inhibition in ApoE KO Mice Using a Schizophyllan-based Antisense Oligonucleotide Therapy
por: Amati, Francesca, et al.
Publicado: (2012)

Astragalus Flavone Ameliorates Atherosclerosis and Hepatic Steatosis Via Inhibiting Lipid-Disorder and Inflammation in apoE(−/−) Mice
por: Ma, Chuanrui, et al.
Publicado: (2020)

microRNA-483 ameliorates hypercholesterolemia by inhibiting PCSK9 production
por: Dong, Jianjie, et al.
Publicado: (2020)

Berberine ameliorates non-alcoholic steatohepatitis in ApoE(−/−) mice
por: Yang, Jin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e7fg1fg8kte1fa9edsrlr5gavu